Protagonist Therapeutics, Inc. (PTGX) stock analysis
In our weekly check, Protagonist Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 5, red flags: 5.
About Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PTGX.
What our checks show for PTGX
Red flags
- Operating cash flow is only 0.32x net profit: part of the reported profit does not arrive as cash.
- Analysts expect revenue to shrink about 10.7% a year.
- Analysts expect the net margin to shrink by 15.3 points from today's 62%.
- The stock has fallen as much as 86% from a peak. Would you have held through that?
- Beta 1.79: the stock usually moves more than the market, both up and down.
Warning signs
- Analysts expect earnings per share to shrink about 27.5% a year.
- The price swings a lot: 39.7% annual volatility. Expect large ups and downs.
- Recovering from its deepest fall took about 2.7 years.
- The share count grew by 12% in 2 years: each shareholder owns a smaller slice.
- Pay in shares equals 49.1% of free cash flow: it dilutes shareholders.
Strengths
- Debt is low: 0.01x equity.
- The net margin rose by 521 points over 5 years, to 62%.
- Revenue grew 175% a year over the last 3 years.
- Earnings per share grew 27% a year over the last 3 years.
- The company keeps 62% of its revenue as net profit.
- Free cash flow is 19.8% of revenue: cash for dividends, buybacks or growth.
Similar companies
KRYS · RYTM · PRAX · CYTK · ABVX · TGTX
Questions
What grade does Protagonist Therapeutics, Inc. (PTGX) have?
In our weekly check, Protagonist Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 5, red flags: 5. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of PTGX stock?
This week's biggest flags for Protagonist Therapeutics, Inc.: Profits not backed by cash, Weak revenue forecast, Margins expected to shrink. In total 10 of 22 checks show a warning or a red flag.
What does Protagonist Therapeutics, Inc. do?
Protagonist Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PTGX.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis